Related Experiment Videos
Anatomic changes in the abdominal cavity during intraperitoneal chemotherapy: prospective study using scintigraphic
1Départment of Medical Oncology, Centre Claudius-Regaud, Toulouse, France.
Bulletin Du Cancer
|April 1, 1993
Summary
Scintigraphic peritoneography revealed significant intraperitoneal (ip) changes in 52% of patients receiving ip chemotherapy. This imaging technique helps identify patients with inadequate drug distribution, even without clinical complications, guiding treatment suitability.
Area of Science:
- Oncology
- Medical Imaging
Background:
- Intraperitoneal (ip) chemotherapy is used for adjuvant or palliative treatment.
- Assessing drug distribution within the peritoneal cavity is crucial for treatment efficacy.
Purpose of the Study:
- To evaluate the utility of scintigraphic peritoneography in assessing intraperitoneal chemotherapy distribution.
- To determine if scintigraphic findings correlate with clinical status and complications.
Main Methods:
- Twenty-one patients undergoing ip chemotherapy had repeated scintigraphic peritoneographies.
- Scintigraphic findings were analyzed for significant changes in ip distribution.
- Correlation between scintigraphic alterations and clinical complications was assessed.
Main Results:
- Significant scintigraphic ip changes were observed in 11 out of 21 patients (52%).
- In patients without residual disease, mal-distribution reached 70%.
- These scintigraphic alterations did not correlate with clinical complications.
Conclusions:
- Scintigraphic peritoneography is a valuable tool for assessing intraperitoneal chemotherapy distribution.
- The technique can identify patients with inadequate locoregional distribution, irrespective of clinical assessment.
- Findings suggest that scintigraphy can guide decisions regarding suitability for continued ip treatment.